Antifungal therapy – Page 3

Fungus-targeted nanomicelles enable microRNA delivery for suppression of virulence in Aspergillus fumigatus as a novel antifungal approach

mycolabadmin

Researchers developed a new way to fight dangerous fungal infections caused by Aspergillus fumigatus by using tiny particles called nanomicelles to deliver genetic material (microRNAs) directly into fungal cells. These microRNAs target and reduce the production of melanin, a protective pigment that helps the fungus resist immune attacks. By weakening this defense, the fungal cells become more vulnerable to the body’s immune system and to stress, offering a novel approach to treat serious fungal infections that have become resistant to standard antifungal drugs.

ABPA in post-tuberculosis lung disease: A diagnostic pitfall or genuine entity?

mycolabadmin

This article addresses confusion between two Aspergillus lung infections that commonly occur after tuberculosis: ABPA and CPA. While they have overlapping symptoms and test results, they require different treatments—ABPA responds to short-term steroids while CPA needs prolonged antifungal drugs. Importantly, giving steroids for misdiagnosed CPA can be harmful, so doctors should be cautious about diagnosing ABPA in tuberculosis survivors and consider CPA instead.

The impact of osteoarticular invasion by Coccidioides Sp disseminated infection

mycolabadmin

A 48-year-old man from Mexico developed a serious fungal infection caused by Coccidioides, which spread from his lungs to his skin, bones, and joints, causing pain and swelling. Despite having a normally functioning immune system, he developed progressive disease that was initially misdiagnosed as rheumatoid arthritis. After switching to the antifungal medication fluconazole, his condition improved dramatically, with symptoms resolving within several months of treatment.

Successful Management of Spondylodiscitis Caused by Aspergillus nidulans: A Case Report and Literature Review

mycolabadmin

A 59-year-old patient with lymphoma developed a serious fungal spine infection caused by Aspergillus nidulans, a rare mold. The infection was diagnosed using imaging, fungal cultures, and laboratory testing. The patient was successfully treated with a 6-month course of the antifungal drug voriconazole without requiring surgery. This case is notable because it represents the first successful treatment of this extremely rare infection in a cancer patient.

Endogenous Endophthalmitis: An underestimated serious complication in patients with disseminated fusariosis

mycolabadmin

An 18-year-old leukemia patient developed a serious fungal eye infection from Fusarium during cancer treatment. The infection spread through the bloodstream to both eyes, causing serious inflammation and vision loss. Doctors treated it with multiple antifungal medications injected directly into the eyes along with systemic medication, which controlled the infection but unfortunately the patient’s vision was significantly affected. This case highlights how rare but serious eye infections can occur in cancer patients with weakened immune systems.

The Prognostic Value of (1→3)-β-D-Glucan in COVID-19 Patients with and Without Secondary Fungal Disease

mycolabadmin

During COVID-19 infection, a fungal marker called beta-D-glucan (BDG) in the blood can predict patient survival even without a diagnosed fungal infection. Researchers found that COVID-19 patients with high BDG levels had a 91% death rate if not treated with antifungal drugs, but this dropped to 50% when antifungal therapy was given. The high BDG levels trigger a strong inflammatory response in the body that worsens disease severity, making BDG a valuable warning sign for doctors treating critically ill COVID-19 patients.

A case of Blastomyces helicus pneumonia in a dog from a non-endemic region: diagnostic challenges and successful treatment outcome

mycolabadmin

A dog from Colorado developed a severe respiratory infection that was initially mistaken for a bacterial pneumonia. After antibiotics failed to help, advanced testing revealed the dog had a fungal infection caused by Blastomyces helicus, a rare fungus found in western North America. The dog was successfully treated with an antifungal medication called itraconazole and made a complete recovery within six months, demonstrating the importance of considering fungal infections when standard treatments fail.

Allergic bronchopulmonary mycosis caused by Scedosporium apiospermum: A case report

mycolabadmin

A 61-year-old woman developed a rare fungal infection in her lungs caused by Scedosporium apiospermum while undergoing cancer treatment. The infection caused persistent cough, mucus plugs in the airways, and high levels of immune cells called eosinophils. Doctors used genetic testing to identify the specific fungus and then treated her with corticosteroids and antifungal medications, which improved her condition significantly.

Traumatic implantation keratitis caused by Schizophyllum commune in Central India

mycolabadmin

This report describes two patients in India who developed serious fungal eye infections (keratitis) after corneal injuries. The infection was caused by Schizophyllum commune, a mushroom-like fungus found on decaying wood. Despite aggressive treatment with antifungal medications and surgery, both patients lost vision in their affected eyes. The case highlights how difficult it is to identify and treat this rare fungus.

Continuous debridement combined with short-term posaconazole therapy for cutaneous mucormycosis caused by Rhizopus oryzae infection secondary to acute myeloid leukemia: a case report

mycolabadmin

An 80-year-old patient with acute myeloid leukemia developed a serious fungal skin infection caused by Rhizopus oryzae on his lower leg. Doctors treated the infection by repeatedly cleaning out the infected tissue and giving him an antifungal medication called posaconazole for just one week. Despite the short treatment duration due to cost concerns, the patient’s wound gradually healed over four months through continued surgical care, showing that sometimes focused surgical treatment can be as effective as long-term medication.

Research Topic: Antifungal therapy